Momentum investing setups in healthcare show biotech stocks with strong Phase 3 clinical data outperforming. High institutional accumulation days suggest sustained price momentum is likely across the small-cap biotech segment. We're getting everything ready for you. The page is loading, and you'll be on your way in just a few moments. Momentum investors don't just pay attention to price changes; positive earnings play a crucial role, too. One analyst revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.37 to $1.9 per share. UNFI boasts an average earnings surprise of 416.2%. Momentum investing in lithium and battery materials is accelerating due to rising EV demand forecasts. Prices are holding firmly above 20-day averages while sector RSI remains in the strong bullish zone.